VRF-CDSI India Special Research Grant
VRF in collaboration with Cosmetic Dermatology Society of India (CDSI) is proud to announce a Special Call for Research Grant Proposals 2012 focused exclusively on India.
Results of epidemiological studies indicate that vitiligo prevalence in India is the highest in the world reaching 8.8% of population affected, thus making India an "epicenter" of vitiligo. On top of that, vitiligo problem in India is further scrutinized by social and cultural features. Together, this makes vitiligo an important issue in India, and places development of novel vitiligo treatment modalities on high demand.
VRF will provide an award for $25,000* for a period of one year to fund an outstanding research proposal(s) in vitiligo area, which is originating from India. According to the VRF's mission, the proposed research could range from basic to clinical science, and its expected results should clearly contribute to development of novel treatment modalities of vitiligo or provide firm scientific basis for that.
We encourage Indian researchers to submit short research proposals to VRF in according to VRF Grant Pre-Application Form for a first round of evaluation. Selected applicants will be eligible to submit full research proposals which will be peer-reviewed to select the most prominent application for funding.
Overview of eligibility criteria and conditions
Principal investigator of the proposed project should have a full-time position in India-based research or clinical unit. Research conducted outside India is not eligible for support under this VRF India Special Grant.
Proposed research should clearly contribute to development of novel treatment modalities of vitiligo or provide firm scientific basis for that.
Approved research project will be financed based on the VRF Research Grant Agreement between VRF and administering organization with which project Principal investigator is affiliated.
Allocated for the winning award funding will be wire-transferred in full as a single payment to the Principal investigator's administering organization.
Grant award is subjected to obligation to submit final report on the work done in the frame of the project within 1 month after project completion.
If awarded, funding should be spent solely to conduct research described in the proposal at the Principal investigator's discretion.Deadlines
April 30, 2012 – Deadline for application pre-submission (short research proposal) for the first round of evaluation.
May 30, 2012 – Announcement of the first round evaluation results and invitation to submit research proposal in full.
August 31, 2012 – Deadline for full proposal submission.
October 30, 2012 – Announcement of grant award
* VRF does not take any commitments to award the grant which will be done solely on the VRF's discretion and is subjected to high scientific quality of the proposal and its significant contribution to unraveling the mystery of vitiligo at a molecular, epidemiological or clinical level.
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
VI Master Class on Vitiligo and Pigmentary Disorders in Croatia
VI Master Class on Vitiligo and Pigmentary Disorders (originally scheduled for Fall 2014) will be held under the presidency of Prof. Anrija Stanimirovic in a picturesq...01 May 2015 09:00, Radisson Blu Resort, Put Trstenika...
New York Vitiligo Support Group meeting
Vitiligo NY group meeting will be taking place on Wednesday, May 6th. We are so thrilled by the positive feedback we have received about the last meeting! We are excit...06 May 2015 18:30, 11th floor of NYU's Ambulatory Car...
Is it possible to stop the progression of vitiligo?
It is true that vitiligo progression could be stopped in 4 out of 5 cases by the use of potent systemic corticosteroids. However, systemic corticosteroids might ha...
Can Scenesse be used for vitiligo treatment?
The drug Scenesse from Clinuvel has been tested in clinical trials in relation vitiligo. Profs. Henry Lim, Mark Lebwohl and coauthors reported (PubMed) results of mult...
Polypodium leucotomos as an adjunct treatment for vitiligo?
Extracts of the tropical fern Polypodium leucotomos appear to possess beneficial properties for the vitiligious skin. Polypodium leucotomos (also classified as Polypo...
Is it covered by Medicare?
A Medicare rebate applies to a percentage of the consultation cost, please consult your GP for a referral to a dermatologist. Narrow band phototherapy (NB-UVB) is full...